The Journal of Alzheimer's Disease was first published in 1998 with the objective of understanding the causes, psychology, pathogenesis, and treatment of Alzheimer's disease, a form of dementia. It contains research, hypotheses, and reviews, as well as letters to the editor. The journal is a member of the Neuroscience Peer Review Consortium, and it is indexed in over 20 databases, including PubMed and EBSCO. It publishes 20 times a year, and its impact factor is 3.612, according to the 2013 Journal Citation Reports.
- Green Tea, Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction, 2011
- Ginger for Inflammation, Curcuminoid binds to amyloid - β1-42 oligomer and fibril, 2011
- Turmeric, Curcuminoid binds to amyloid - β1-42 oligomer and fibril, 2011